Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Ultrasound Obstet Gynecol ; 51(4): 519-523, 2018 Apr.
Article in English | MEDLINE | ID: mdl-28436119

ABSTRACT

OBJECTIVE: Pre-eclampsia (PE) is associated with maternal cardiac remodeling and diastolic dysfunction. The aim of this study was to assess and compare maternal left ventricular structure and diastolic function and levels of brain natriuretic peptide (BNP) in women with early-onset (< 34 weeks' gestation) vs those with late-onset (≥ 34 weeks' gestation) PE. METHODS: This was a prospective, cross-sectional, observational study of 30 women with early-onset PE, 32 with late-onset PE and 23 normotensive controls. Maternal cardiac structure and diastolic function were assessed by echocardiography and plasma levels of BNP were measured by enzyme immunoassay. RESULTS: Early- and late-onset PE were associated with increased left ventricular mass index and relative wall thickness compared with normotensive controls. In women with early-onset PE, the prevalence of concentric hypertrophy (40%) and diastolic dysfunction (23%) was also significantly higher (both P < 0.05) compared with women with late-onset PE (16% for both). Maternal serum BNP levels were significantly higher (P < 0.05) in women with early-onset PE and correlated with relative wall thickness and left ventricular mass index. CONCLUSIONS: Early-onset PE is associated with more severe cardiac impairment than is late-onset PE, as evidenced by an increased prevalence of concentric hypertrophy, diastolic dysfunction and higher levels of BNP. These findings suggest that early-onset PE causes greater myocardial damage, increasing the risk of both peripartum and postpartum cardiovascular morbidity. Although these cardiovascular effects are easily identified by echocardiographic parameters and measuring BNP, further studies are needed to assess their clinical utility. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.


Subject(s)
Hypertrophy, Left Ventricular/blood , Hypertrophy, Left Ventricular/physiopathology , Natriuretic Peptide, Brain/blood , Pre-Eclampsia/blood , Pre-Eclampsia/physiopathology , Ventricular Dysfunction, Left/physiopathology , Adult , Biomarkers/blood , Cross-Sectional Studies , Disease Progression , Echocardiography , Female , Humans , Pregnancy , Prospective Studies , Risk Factors , Ventricular Dysfunction, Left/etiology , Young Adult
2.
Kidney Blood Press Res ; 29(5): 273-9, 2006.
Article in English | MEDLINE | ID: mdl-17035712

ABSTRACT

The aim of this study is to evaluate if hemodialysis (HD) patients with similar blood pressure (BP) in the whole inter-HD period could have different target organ lesions and survival if the behavior of BP differs from the first to the second day of the inter-HD period. The present study compares 44-hour ambulatory BP monitoring (ABPM) patterns in 45 HD patients. Three BP patterns emerged: group A (n = 15) had similar BPs throughout (138 +/- 11/88 +/- 12 in the first 22 h vs. 140 +/- 11/87 +/- 12 mm Hg in the second 22-hour period); group B (n = 15) had a significant systolic BP rise from the first to the second period (132 +/- 15/80 +/- 12 vs. 147 +/- 12/86 +/- 13 mm Hg, p < 0.05); group C (n = 15) had significantly higher BPs (p < 0.05) than the other 2 groups throughout the whole inter-HD period, with no significant change between the 2 halves (172 +/- 14/108 +/- 12 vs. 173 +/- 18/109 +/- 14 mm Hg). Ventricular mass and survival during the 30-month follow-up period were statistically significantly better in group A, intermediate in group B and worse in group C. The data suggest that a 44-hour ABPM is more accurate than a 24-hour one in evaluating organ lesion and prognosis in HD patients.


Subject(s)
Blood Pressure Monitoring, Ambulatory/methods , Kidney Failure, Chronic/physiopathology , Kidney Failure, Chronic/therapy , Renal Dialysis/methods , Adult , Aged , Algorithms , Antihypertensive Agents/therapeutic use , Echo-Planar Imaging , Electrocardiography , Female , Heart Rate/physiology , Humans , Hypertension/complications , Hypertension/diagnosis , Hypertension/physiopathology , Kidney Failure, Chronic/mortality , Kidney Function Tests , Male , Middle Aged , Survival Analysis
3.
Braz J Med Biol Res ; 37(11): 1707-12, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15517087

ABSTRACT

Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, and most people have serological evidence of previous viral infection at adult age. EBV is associated with infectious mononucleosis and human cancers, including some lymphomas and gastric carcinomas. Although EBV was first reported in lymphoepithelioma-like gastric carcinoma, the virus was also found in conventional adenocarcinomas. In the present study, 53 gastric carcinomas diagnosed in São Paulo State, Brazil, were evaluated for EBV infection by non-isotopic in situ hybridization with a biotinylated probe (Biotin-AGACACCGTCCTCACCACCC GGGACTTGTA) directed to the viral transcript EBER-I, which is actively expressed in EBV latently infected cells. EBV infection was found in 6 of 53 (11.32%) gastric carcinomas, mostly from male patients (66.7%), with a mean age of 59 years old. Most EBV-positive tumors were in gastric antrum. Two EBV-positive tumors (33.3%) were conventional adenocarcinomas, whereas four (66.7%) were classified as lymphoepithelioma-like carcinomas. EBV infection in gastric carcinomas was reported elsewhere in frequencies that range from 5.6% (Korea) up to 18% (Germany). In Brazil, a previous work found EBV infection in 4 of 80 (5%) gastric carcinomas, whereas another study found 4.7 and 11.2% of EBV-positive gastric carcinomas of Brazilians of Japanese origin or not, respectively. In the present study, the frequency of EBV-positive gastric carcinomas is similar to that reported in other series, and the clinicopathologic characteristics of these EBV-positive tumors are in agreement with the data in the literature.


Subject(s)
Adenocarcinoma/virology , Epstein-Barr Virus Infections/diagnosis , Herpesvirus 4, Human/isolation & purification , Stomach Neoplasms/virology , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Brazil , Epstein-Barr Virus Infections/pathology , Female , Humans , In Situ Hybridization , Male , Middle Aged , RNA, Viral/analysis , Stomach Neoplasms/pathology
4.
Braz. j. med. biol. res ; 37(11): 1707-1712, Nov. 2004. ilus, tab
Article in English | LILACS | ID: lil-385872

ABSTRACT

Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, and most people have serological evidence of previous viral infection at adult age. EBV is associated with infectious mononucleosis and human cancers, including some lymphomas and gastric carcinomas. Although EBV was first reported in lymphoepithelioma-like gastric carcinoma, the virus was also found in conventional adenocarcinomas. In the present study, 53 gastric carcinomas diagnosed in São Paulo State, Brazil, were evaluated for EBV infection by non-isotopic in situ hybridization with a biotinylated probe (Biotin-AGACACCGTCCTCACCACCC GGGACTTGTA) directed to the viral transcript EBER-I, which is actively expressed in EBV latently infected cells. EBV infection was found in 6 of 53 (11.32 percent) gastric carcinomas, mostly from male patients (66.7 percent), with a mean age of 59 years old. Most EBV-positive tumors were in gastric antrum. Two EBV-positive tumors (33.3 percent) were conventional adenocarcinomas, whereas four (66.7 percent) were classified as lymphoepithelioma-like carcinomas. EBV infection in gastric carcinomas was reported elsewhere in frequencies that range from 5.6 percent (Korea) up to 18 percent (Germany). In Brazil, a previous work found EBV infection in 4 of 80 (5 percent) gastric carcinomas, whereas another study found 4.7 and 11.2 percent of EBV-positive gastric carcinomas of Brazilians of Japanese origin or not, respectively. In the present study, the frequency of EBV-positive gastric carcinomas is similar to that reported in other series, and the clinicopathologic characteristics of these EBV-positive tumors are in agreement with the data in the literature.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Adenocarcinoma/virology , Epstein-Barr Virus Infections/diagnosis , /isolation & purification , Stomach Neoplasms/virology , Adenocarcinoma/pathology , Brazil , Epstein-Barr Virus Infections/pathology , In Situ Hybridization , RNA, Viral/analysis , Stomach Neoplasms/pathology
5.
J Clin Pathol ; 51(3): 204-6, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9659260

ABSTRACT

AIMS: To evaluate the prevalence of pseudoangiomatous hyperplasia of mammary stroma in gynaecomastia and its immunohistochemical profile in this setting. METHODS: Eighty eight cases of gynaecomastia recovered from the files of the department of pathology, Botucatu School of Medicine from 1976 to 1996 were studied. In the cases associated with pseudoangiomatous hyperplasia of mammary stroma, immunoreactivity for cytokeratins (CAM 5.2), vimentin, CD34, factor VIII related antigen, and the oestrogen and progesterone receptors were studied. RESULTS: Pseudoangiomatous hyperplasia of mammary stroma was found in 21 of 88 cases of gynaecomastia (23.8%). In all cases, the cells lining the spaces were positive for vimentin, whereas CAM 5.2 and factor VIII related antigen were consistently negative. Nineteen of the 21 cases showed immunoreactivity for CD34. Ductal epithelial cells were positive for both the oestrogen receptor and the progesterone receptor, whereas stromal cells were negative. CONCLUSIONS: Pseudoangiomatous hyperplasia of mammary stroma was present in approximately one quarter of the cases of gynaecomastia. This immunohistochemical study confirms the mesenchymal origin of the stromal cells that line the pseudovascular spaces, as has been found in female cases of pseudoangiomatous hyperplasia of mammary stroma.


Subject(s)
Angiomatosis/pathology , Breast/pathology , Gynecomastia/pathology , Adolescent , Adult , Angiomatosis/etiology , Angiomatosis/metabolism , Antigens, CD34/metabolism , Breast/metabolism , Child , Gynecomastia/complications , Humans , Hyperplasia/etiology , Hyperplasia/metabolism , Hyperplasia/pathology , Immunohistochemistry , Male , Vimentin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL